Efficacy and safety of SY-5007, a highly potent and selective RET inhibitor, in Chinese patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC): Results from a multicenter, single-arm, phase II study

被引：0
|
作者：
Xiong, Anwen
Li, XingYa
Yang, Nong
Meng, Xiangjiao
Yu, Qitao
Tan, Liping
Wang, Qiming
Wang, Yongsheng
Liu, Baogang
Luo, Hui
Wang, Ying
Huang, Dingzhi
Zhang, Yiping
Song, Zhengbo
Ye, Feng
Fang, Jian
Zhao, Mingfang
Wang, Yongsheng
Sun, Yinghui
Zhou, Caicun
机构：
[1] Tongji Univ, Shanghai Pulm Hosp, Dept Med Oncol, Canc Inst,Sch Med, Shanghai, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Dept Med Oncol, Zhengzhou, Peoples R China
[3] Cent South Univ, Lung Canc & Gastrointestinal Unit, Dept Med Oncol,Xiangya Sch Med, Hunan Canc Hosp,Affiliated Canc Hosp, Changsha, Peoples R China
[4] Shandong Canc Hosp, Jinan, Peoples R China
[5] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Resp Oncol, Nanning, Peoples R China
[6] Zhengzhou Univ, Henan Canc Hosp, Dept Internal Med, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[7] Sichuan Univ, West China Hosp, Clin Trial Ctr, Chengdu, Peoples R China
[8] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
[9] Jiangxi Canc Hosp, Dept Thorac Tumor Radiotherapy Ward 2, Nanchang, Jiangxi, Peoples R China
[10] Chongqing Univ, Canc Hosp, Dept Radiat Oncol, Chongqing, Peoples R China
[11] Chongqing Canc Inst, Chongqing, Peoples R China
[12] Chongqing Canc Hosp, Chongqing, Peoples R China
[13] Tianjin Med Univ, Tianjin Canc Inst & Hosp, Tianjin, Peoples R China
[14] Zhejiang Canc Hosp, Dept Thorac Oncol, Hangzhou, Peoples R China
[15] Xiamen Univ, Affiliated Hosp 1, Dept Med Oncol, Xiamen, Peoples R China
[16] Peking Univ Canc Hosp & Inst, Dept Thorac Oncol 2, Beijing, Peoples R China
[17] China Med Univ, Dept Med Oncol, Hosp 1, Shenyang, Peoples R China
[18] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Resp Med, Nanjing, Peoples R China
[19] Shouyao Holdings Beijing Co Ltd, Dept Clin Med, Beijing, Peoples R China
[20] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Oncol, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3106
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of DCVAC/LuCa Treatment plus standard chemotherapy and TCM in patients with advanced non-small cell lung cancer: A single-arm phase II study.
    Lou, Yanni
    Jia, Liqun
    Liu, Qing
    Li, Liya
    Cui, Huijuan
    Deng, Chao
    Liu, Meng
    Su, Fei
    Cheng, Zhiqiang
    Wan, Donggui
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [42] Efficacy and safety of sunitinib in previously treated, advanced non-small cell lung cancer (NSCLC): Preliminary results of a multicenter phase II trial.
    Socinski, M. A.
    Novello, S.
    Sanchez, J. M.
    Brahmer, J. A.
    Govindan, R.
    Belani, C. P.
    Atkins, J. N.
    Gillenwater, H. H.
    Palleres, C.
    Chao, R. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 364S - 364S
  • [43] PHASE II SINGLE-ARM STUDY OF PREOPERATIVE PEMETREXED (P) PLUS CISPLATIN (C) IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Chabowski, M.
    Ramlau, R.
    Dyszkiewicz, W.
    Chouaki, N.
    Soldatenkova, V.
    Varea, R.
    Barriga, S.
    Visseren-Grul, C. M.
    Orlowski, T.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 395 - 395
  • [44] A multicenter phase II study of sorafenib in combination with erlotinib patients with advanced non-small cell lung cancer (NSCLC)
    Cho, B.
    Kim, S.
    Heo, D. S.
    Kang, S.
    Kim, H.
    Lee, D.
    Kim, D.
    Jung, M.
    Choi, J.
    Kim, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] A multicenter single-arm phase II study of nab-paclitaxel/carboplatin for non-small cell lung cancer patients with interstitial lung disease
    Usui, Y.
    Kenmotsu, H.
    Mori, K.
    Ono, A.
    Yoh, K.
    Baba, T.
    Fujiwara, Y.
    Yamaguchi, O.
    Ko, R.
    Okamoto, H.
    Yamamoto, N.
    Ninomiya, T.
    Ogura, T.
    Kato, T.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [46] Efficacy and safety of carboplatin and pemetrexed followed by maintenance with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer: A single-arm, open-label, multicenter, phase II study
    Shinoda, Masahiro
    Shinkai, Masaharu
    Hara, Yu
    Tomaru, Kouji
    Manabe, Saki
    Murakami, Syuji
    Saito, Haruhiro
    Kobayashi, Nobuaki
    Miyazawa, Naoki
    Nishikawa, Masanori
    Kaneko, Takeshi
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (06) : 486 - 494
  • [47] Single-arm, phase II study of pyrotinib in advanced non-small cell lung cancer (NSCLC) patients with HER2 exon 20 mutation.
    Gao, Guanghui
    Li, Xingya
    Wang, Qiming
    Zhang, Yiping
    Chen, Jianhua
    Shu, Yongqian
    Hu, Yanping
    Fan, Yun
    Fang, Jian
    Chen, Gongyan
    Zhao, Jun
    He, Jianxing
    Wu, Fengying
    Zou, Jianjun
    Zhu, Xiaoyu
    Zhou, Caicun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] LURET: Final survival results of the phase II trial of vandetanib in patients with advanced RET-rearranged non-small cell lung cancer
    Yoh, K.
    Seto, T.
    Satouchi, M.
    Nishio, M.
    Yamamoto, N.
    Murakami, H.
    Nogami, N.
    Kuroda, S.
    Nomura, S.
    Sato, A.
    Tsuchihara, K.
    Kohno, T.
    Matsumoto, S.
    Goto, K.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [49] A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
    Hisashi Tanaka
    Kageaki Taima
    Takeshi Morimoto
    Yoshihito Tanaka
    Masamichi Itoga
    Kunihiko Nakamura
    Akihito Hayashi
    Mika Kumagai
    Hideo Yasugahira
    Megumi Mikuniya
    Koichi Okudera
    Shingo Takanashi
    Sadatomo Tasaka
    [J]. BMC Cancer, 17
  • [50] Intracranial Activity of Selpercatinib in Chinese Patients With Advanced RET Fusion-Positive Non-Small-Cell Lung Cancer in the Phase II LIBRETTO-321 Trial
    Cheng, Ying
    Huang, Dingzhi
    Zhou, Jianying
    Zhou, Chengzhi
    Sun, Yuping
    Wu, Lin
    Guo, Ye
    Shao, Jingxin
    Zhang, Wanli
    Lu, Shun
    [J]. JCO PRECISION ONCOLOGY, 2023, 7
12345